methylprednisolone has been researched along with Wallerian Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broglio, L; Cavallaro, T; Cotelli, M; Ferrari, S; Filosto, M; Padovani, A; Pasolini, G; Tentorio, M | 1 |
| Alderazi, Y; Counihan, TJ; Elamin, M; Farrell, MA; Mullins, G; O'Connell, S | 1 |
| Bilge, T; Celik, SE; Cokar, N; Gül, S; Kalayci, M; Taşyürekli, M | 1 |
3 other study(ies) available for methylprednisolone and Wallerian Degeneration
| Article | Year |
|---|---|
Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy.
Topics: Anti-Inflammatory Agents; Axons; Azathioprine; Biopsy; Complement System Proteins; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Peripheral Nerves; Peripheral Nervous System Diseases; Sural Nerve; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous; Wallerian Degeneration | 2009 |
Perineuritis in acute lyme neuroborreliosis.
Topics: Anti-Bacterial Agents; Arm; Axons; Biopsy; Ceftriaxone; Chemotaxis, Leukocyte; Humans; Immunosuppressive Agents; Leg; Lyme Neuroborreliosis; Male; Methylprednisolone; Middle Aged; Muscle Weakness; Neuritis; Peripheral Nerves; Sural Nerve; Treatment Outcome; Wallerian Degeneration | 2009 |
Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Axons; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Lipid Peroxidation; Melatonin; Methylprednisolone; Microscopy, Electron, Transmission; Myelin Sheath; Nerve Fibers, Myelinated; Neuroprotective Agents; Rats; Rats, Wistar; Spinal Cord Injuries; Treatment Outcome; Wallerian Degeneration | 2005 |